CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to combat antibiotic resistance by using engineered bacteriophages to restore the effectiveness of existing antibiotics against resistant pathogens. The phages deliver genetic constructs to pathogens, making them sensitive to antibiotics without directly killing them, thus enhancing treatment options…
Antibiotic resistance of pathogens is an accelerating problem and there is an urgent need for new antimicrobial agents.
Pharmaceutical companies face numerous obstacles in developing new antibiotics, and therefore a method that will re-sensitize pathogens to well-established antibiotics harbors key advantages.
We propose a system that restores antibiotic efficiency by reversing resistance of pathogens.
The system utilizes bacteriophages, which possess engineering capabilities and are excellen…
TEL AVIV UNIVERSITY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
